Start a live chat
1-800-870-4800
NMN and sirtuins —
what the research shows
about how they are connected.
Nicotinamide mononucleotide (NMN) is a NAD+ precursor — a molecule the body converts into NAD+, the cofactor that every sirtuin in the cell requires to function. The NMN–NAD+–sirtuin chain is the central mechanistic connection in the longevity research literature on NMN. Understanding what sirtuins actually do, why they require NAD+, and what the research literature has examined about NMN's role in that system is the most direct path to understanding what NMN biology is actually about.
I
What NMN is —
and what it does in the NAD+ system.
Nicotinamide mononucleotide — NMN — is a naturally occurring molecule found in small amounts in many foods and produced inside the body through the Salvage Pathway, the primary route by which cells recycle nicotinamide back into NAD+. NMN is the penultimate intermediate in that pathway: the enzyme NAMPT converts nicotinamide into NMN, and the enzyme NMNAT then converts NMN into NAD+. NMN is therefore one biosynthetic step from NAD+ — a direct precursor in the most active NAD+ production pathway the cell runs.
The reason NMN has attracted significant research attention in the longevity field is not because NMN is itself the biologically active molecule. It is because NAD+ — the molecule NMN becomes — is a cofactor that the sirtuin family of enzymes requires for every regulatory reaction it performs. Sirtuins are among the most extensively studied longevity-relevant proteins in biology: they govern gene expression, DNA maintenance, epigenetic regulation, and metabolic coordination in virtually every tissue. Their activity is stoichiometrically dependent on NAD+ — meaning the size of the cellular NAD+ pool directly determines how actively they can operate. And that pool, across multiple independent lines of evidence, declines with age. NMN research is, at its core, research into whether supporting the NAD+ precursor supply can influence the capacity of this sirtuin-mediated regulatory system. The research literature has examined this question extensively in animal models and, more recently, in early-stage human studies. Studies were conducted independently and did not involve any specific Codeage product.
The NMN–NAD+ connection runs through the Salvage Pathway — the same recycling loop covered in the Salvage Pathway article. The rate-limiting enzyme of that pathway — NAMPT — is the primary determinant of how much NMN the cell can make endogenously, and NAMPT's activity declines with age in a pattern consistent with the broader NAD+ decline documented across tissues. Understanding NMN supplementation in a research context means understanding it as a way of supplying the NMN substrate that NAMPT's age-related decline produces less of — not as a molecule that acts directly on any biological target, but as a precursor that feeds the pathway that makes the cofactor that sirtuins require.
NMN is not the active molecule.
NAD+ is.
NMN is the precursor
that the body converts into NAD+ —
and NAD+ is what every sirtuin
in the cell consumes
to do its work.
The Sirtuin Family — Seven NAD+-Dependent Enzymes
What each of the seven sirtuins does —
and why all of them depend on NAD+.
Every sirtuin consumes one molecule of NAD+ per regulatory reaction. Their substrates span the nucleus, cytoplasm, and mitochondrial matrix — making the NAD+ pool the single shared currency of sirtuin activity across the entire cell.
The most studied sirtuin — regulates epigenetic marks, gene expression, autophagy, and the stress response
SIRT1 is the mammalian ortholog of yeast Sir2, the sirtuin first identified in longevity research. It deacetylates histones H3K9ac and H3K14ac (silencing gene promoters), p53 (modulating cell cycle arrest and apoptosis decisions), NF-κB (restraining inflammatory gene expression), PGC-1α (activating mitochondrial biogenesis), FOXO transcription factors (activating stress resistance genes), and the autophagy proteins ATG5, ATG7, and LC3 (initiating autophagy). SIRT1 is arguably the most connected regulatory enzyme in longevity biology — its substrates span metabolism, epigenetics, inflammation, mitochondrial function, and protein quality control. Every one of its deacetylation reactions consumes one NAD+ molecule. Studies were conducted independently and did not involve any specific Codeage product.
Primarily cytoplasmic — regulates the cell cycle, tubulin acetylation, and metabolic enzyme activity
SIRT2 is primarily cytoplasmic and has its highest activity during mitosis, where it deacetylates α-tubulin to regulate microtubule dynamics and chromosome segregation fidelity. Outside of the cell cycle, SIRT2 deacetylates and regulates PEPCK1 (a key gluconeogenesis enzyme), FOXO3a (stress response transcription factor), and several metabolic enzymes. SIRT2 has been studied in the context of age-related changes in cytoskeletal and metabolic regulation. Like all sirtuins, its enzymatic activity is stoichiometrically coupled to NAD+ — one molecule consumed per substrate deacetylation.
The primary mitochondrial sirtuin — the most extensively documented NAD+-dependent regulator of mitochondrial function
SIRT3 is the most active sirtuin in the mitochondrial matrix, with over 100 documented substrate proteins spanning the electron transport chain, citric acid cycle, fatty acid oxidation, and reactive oxygen species management. Its best-characterized substrates include MnSOD (manganese superoxide dismutase, the primary mitochondrial antioxidant enzyme), Complex I and III of the electron transport chain, acetyl-CoA synthetase 2, and several citric acid cycle enzymes. SIRT3 is the mitochondrial sirtuin most extensively linked to longevity biology in animal model research — SIRT3 knockout mice show accelerated features of mitochondrial aging, while SIRT3 overexpression has been associated with favorable metabolic outcomes in multiple studies. It draws on the mitochondrial NAD+ pool maintained by NMNAT3 — the sole NAD+-synthesizing enzyme in the matrix, which converts NMN into NAD+ inside the mitochondrion. Studies referenced were conducted independently and did not involve any specific Codeage product.
An ADP-ribosyltransferase that regulates amino acid metabolism and the mitochondrial response to caloric abundance
SIRT4 is unusual among the sirtuins in that its primary enzymatic activity is ADP-ribosyltransferase rather than deacetylase — it consumes NAD+ to transfer an ADP-ribose group to target proteins rather than to remove an acetyl group. Its best-characterized role is the inhibition of glutamate dehydrogenase (GDH) through ADP-ribosylation, reducing the use of amino acids as energy substrates when caloric availability is high. SIRT4 also has documented deacylase activity and participates in the mitochondrial response to DNA damage. Like all sirtuins, its activity is coupled to the NAD+ pool in the mitochondrial matrix.
Specializes in removing long-chain acyl modifications — desuccinylase, demalonylase, deglutarylase
SIRT5 removes longer acyl modifications — succinyl, malonyl, and glutaryl groups — from mitochondrial proteins, in contrast to SIRT3 which primarily removes acetyl groups. These long-chain modifications accumulate on mitochondrial metabolic enzymes as byproducts of the citric acid cycle and fatty acid synthesis intermediates, and can alter enzyme activity when they accumulate. SIRT5 substrates include enzymes of the citric acid cycle, the urea cycle, and fatty acid oxidation. Its activity also requires NAD+ from the same NMNAT3-supplied pool shared with SIRT3 and SIRT4.
Nuclear sirtuin with the most direct connection to genomic stability, telomere maintenance, and DNA damage responses
SIRT6 is a nuclear sirtuin with a substrate profile focused on genomic maintenance rather than metabolic regulation. It deacetylates H3K9ac and H3K56ac at telomeric regions (maintaining telomere chromatin integrity as covered in the telomeres article), at DNA double-strand break sites (coordinating the DNA damage repair response), and at the promoters of NF-κB target genes (restraining inflammatory gene expression). SIRT6 overexpression in male mice extends lifespan; SIRT6 knockout produces a premature aging syndrome with accelerated telomere dysfunction and genomic instability. SIRT6's activity is dependent on the nuclear NAD+ pool maintained by NMNAT1, which converts NMN into NAD+ in the nucleus. Studies were conducted independently and did not involve any specific Codeage product.
Nucleolar sirtuin — regulates ribosomal RNA transcription and the cellular stress response
SIRT7 localizes primarily to the nucleolus, the nuclear compartment responsible for ribosomal RNA (rRNA) transcription and ribosome assembly. It deacetylates and activates RNA polymerase I (the enzyme that transcribes rRNA) and regulates several transcription factors involved in cellular stress responses, including p53 and NF-κB. SIRT7 has been studied in the context of cardiac aging — SIRT7 knockout mice show cardiac hypertrophy and inflammatory cardiomyopathy — and in the regulation of protein quality control through its roles in the unfolded protein response. As with all sirtuins, its deacetylase activity requires NAD+, sourced from the nuclear pool maintained by NMNAT1.
II
Why the NAD+ pool matters
for sirtuin function — and what NMN research has examined.
The stoichiometry of sirtuin catalysis — one NAD+ consumed per deacetylation reaction — means that sirtuin activity is not merely influenced by NAD+ availability; it is governed by it. A cell with an abundant NAD+ pool can run its sirtuin-mediated regulatory programs at full capacity. A cell with a depleted NAD+ pool cannot, regardless of how much of the sirtuin protein is present. The question of what determines NAD+ availability in aging cells is therefore the question of what limits sirtuin function — and it is the central question that NMN research has attempted to address.
The NAD+ decline with age has been documented across multiple tissues in rodents and, more recently, in human studies. The decline is mechanistically attributed to two primary factors: reduced activity of NAMPT — the rate-limiting enzyme that converts nicotinamide to NMN in the Salvage Pathway — and increased consumption of NAD+ by CD38, an NAD+ase whose expression on immune cells rises with the chronic inflammatory state of aging. The compounding of these two forces — less production, more degradation — produces the net NAD+ decline that has been reproducibly measured. NMN supplementation in this context is studied as a way to supply NMN directly, bypassing the NAMPT bottleneck and providing substrate for the downstream NMNAT enzymes that complete the conversion to NAD+. Whether this exogenous supply translates into meaningful changes in the NAD+ pool — and whether those changes affect sirtuin activity — is the core research question. The literature examining this question in rodent models is extensive; human studies are at an earlier stage and continue to accumulate. The evolving state of this field means what is described here reflects current understanding, and the research landscape will look more detailed in the years ahead.
Three compartments of the cell maintain separate NAD+ pools: the nucleus (supplied by NMNAT1), the cytoplasm (supplied by NMNAT2), and the mitochondrial matrix (supplied by NMNAT3). NMN is the shared substrate for all three — meaning it is the precursor that, once inside the cell, can feed whichever compartmental pool has the highest demand. The distribution of NMN between compartments is not fully characterized in all cell types, and the compartment-specificity of sirtuin activity — SIRT1 and SIRT6 in the nucleus, SIRT2 in the cytoplasm, SIRT3/4/5 in the mitochondrial matrix — means that the NAD+-sirtuin connection is not a single unified system but three overlapping ones, each with distinct regulatory significance. For the full picture of the Salvage Pathway and how NAD+ is made from NMN, the Salvage Pathway article covers the biochemistry in depth.
The NMN–NAD+–Sirtuin Chain
Three steps — from NMN precursor
to sirtuin regulatory activity.
Step 01 · NMN → NAD+
NMN is converted to NAD+ by the NMNAT enzyme family in three separate cellular compartments
After entering the cell, NMN is converted to NAD+ by one of three NMNAT isoforms: NMNAT1 in the nucleus, NMNAT2 in the cytoplasm, NMNAT3 in the mitochondrial matrix. This final biosynthetic step completes the NAD+ molecule from the NMN precursor — adding AMP to NMN's phosphate group to form the full NAD+ structure. The three-compartment distribution of NMNAT activity means NMN can, in principle, contribute to NAD+ pools across the entire cell. The rate at which NMN is converted to NAD+ in each compartment depends on local NMNAT activity and the demand from NAD+-consuming enzymes (sirtuins, PARPs, CD38) in that compartment. Studies were conducted independently and did not involve any specific Codeage product.
Step 02 · NAD+ → sirtuin cofactor
NAD+ is consumed by sirtuins at the rate of one molecule per deacetylation — making the pool size the primary determinant of sirtuin capacity
Each time a sirtuin deacetylates a substrate — removing an acetyl group from a lysine residue on a target protein — it cleaves NAD+ into nicotinamide and 2'-O-acetyl-ADP-ribose. The nicotinamide is released and recycled back to NMN by NAMPT, completing the Salvage Pathway loop. The 2'-O-acetyl-ADP-ribose is a signaling molecule with its own downstream effects. The critical point for understanding NMN's relevance is this: the number of sirtuin regulatory reactions the cell can perform per unit time is mathematically bounded by the NAD+ available. When the pool is large, sirtuins can operate at a rate consistent with their substrate load. When the pool is small, a backlog of acetylated substrates accumulates — and the regulatory programs those sirtuins coordinate are attenuated.
Step 03 · Sirtuin → cellular regulation
Sirtuin activity translates into coordinated regulation of epigenetics, mitochondria, inflammation, autophagy, and stress responses
The seven sirtuin substrates collectively govern an extraordinary breadth of cellular biology: SIRT1 coordinates epigenetic maintenance, mitochondrial biogenesis, autophagy, and inflammatory gene restraint; SIRT3 governs mitochondrial energy metabolism and antioxidant defense; SIRT6 maintains telomeric chromatin and restrains NF-κB signaling. The downstream effects of adequate versus inadequate NAD+ on sirtuin function are therefore not narrow — they propagate through the entire regulatory network that sirtuins coordinate. This is the mechanistic basis for the wide-ranging research interest in NAD+ precursors including NMN: not because NAD+ directly produces specific biological outcomes, but because it is the cofactor through which the cell's most consequential regulatory enzymes operate. Studies were conducted independently and did not involve any specific Codeage product.
NMN, NAD+ and Sirtuins in Numbers
What the molecular architecture
of the NMN–sirtuin connection looks like.
7
Sirtuins in the human cell — every one NAD+-dependent, spanning three cellular compartments and governing hundreds of substrate proteins
All seven human sirtuins (SIRT1–7) require NAD+ as a stoichiometric substrate for every regulatory reaction they perform. None can substitute an alternative cofactor. Their combined substrate profile spans histones, transcription factors, metabolic enzymes, DNA repair proteins, and autophagy regulators — making NAD+ the single shared currency of the most broadly connected class of regulatory enzymes in the cell. SIRT3, the most active mitochondrial sirtuin, alone has over 100 documented substrate proteins. Studies were conducted independently and did not involve any specific Codeage product.
3
Separate NAD+ pools in the cell — nuclear (NMNAT1), cytoplasmic (NMNAT2), mitochondrial (NMNAT3) — each supplied from NMN by a distinct NMNAT isoform
The three-compartment architecture of cellular NAD+ means that NMN — the shared precursor for all three NMNAT enzymes — is the upstream molecule that feeds all three pools. The distribution between pools is determined by local NMNAT activity and NAD+ demand; the mitochondrial pool is physically isolated by the inner membrane, making NMNAT3 the sole route to mitochondrial NAD+. This compartmentalization is why SIRT3, SIRT4, and SIRT5 in the matrix draw on a fundamentally different NAD+ supply than SIRT1, SIRT6, and SIRT7 in the nucleus — despite all seven depending on the same precursor molecule.
1
NAD+ molecule consumed per sirtuin deacetylation reaction — the fixed biochemical cost that makes NAD+ pool size the mathematical limit on sirtuin activity
The 1:1 stoichiometry of NAD+ consumption per sirtuin reaction is the molecular fact that makes NAD+ precursor biology directly relevant to sirtuin function. It is not that more NAD+ makes sirtuins "work better" in any qualitative sense — it is that the rate at which sirtuins can perform their regulatory work is bounded by how many NAD+ molecules are available per unit time. The Salvage Pathway, with NAMPT as its rate-limiting step, is what determines that availability endogenously. NMN is the molecule NAMPT produces — and the molecule that NMNAT converts to NAD+. The chain is direct and mechanistically specific.
III
What the NMN and sirtuin research
means for understanding longevity biology.
The NMN–NAD+–sirtuin connection is one of the most mechanistically specific stories in longevity biology. It begins with a documented fact — that the cellular NAD+ pool declines with age across tissues — and follows the molecular consequences of that decline through the sirtuin family's regulatory reach: epigenetic maintenance, mitochondrial function, DNA damage responses, inflammation control, autophagy, and stress resistance. Each of these systems is documented to decline with age in ways that parallel the NAD+ decline; the mechanistic connection through sirtuins provides a plausible explanation for why they might be coupled.
The NMN research literature in animal models has found consistent evidence that NMN administration is associated with increases in tissue NAD+ levels, and that these increases are associated with changes in sirtuin-regulated endpoints across multiple tissues — including skeletal muscle, liver, heart, and brain — in aged rodents. The human research is at a substantially earlier stage: a growing number of clinical trials have examined NMN's effects on NAD+ metabolism and various biomarkers in human subjects, with some finding measurable changes in circulating NAD+ metabolites. The translation of rodent findings to humans, the appropriate context for studying NMN in human populations, and the long-term significance of observed changes are all active areas of research and ongoing characterization. This is a field whose contours will look considerably more defined in the years ahead. All studies were conducted independently and did not involve any specific Codeage product.
What the NMN story ultimately represents is a case study in how longevity biology has evolved from broad observations about aging to mechanistically specific hypotheses about molecular targets. The identification of sirtuins as NAD+-dependent longevity regulators, the documentation of NAD+ decline with age, and the development of NAD+ precursor strategies to address that decline form one of the most coherent research narratives in the field. For the full molecular story of how NMN went from a biochemical curiosity to the center of longevity research, the history of NMN in longevity research covers the arc from yeast aging experiments to current human trials. For the ATP system that NAD+ powers, the ATP article covers the energy system dimension.
The NMN story is not about
a single molecule or effect.
It is about the cofactor
through which the cell's most
consequential regulatory enzymes
operate — and what happens
when its supply declines.
Codeage · Pillar 03 · Cellular Longevity
Built for the
cellular long game.
Cellular Longevity is Pillar 03 of The Longevity Code — the dimension built around NAD+ biology, mitochondrial health, and the science of cellular aging.
Explore Cellular Longevity →
